[{"address1": "18702 North Creek Parkway", "address2": "Suite 100", "city": "Bothell", "state": "WA", "zip": "98011", "country": "United States", "phone": "425 939 7410", "website": "https://immunome.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immunome, Inc., a clinical-stage biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. Its preclinical assets include IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, including IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.", "fullTimeEmployees": 118, "companyOfficers": [{"maxAge": 1, "name": "Dr. Clay B. Siegall Ph.D.", "age": 63, "title": "Chairman, President & CEO", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 1235350, "exercisedValue": 0, "unexercisedValue": 15820780}, {"maxAge": 1, "name": "Mr. Max  Rosett", "age": 34, "title": "Chief Financial Officer", "yearBorn": 1990, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Philip  Tsai", "title": "Chief Technical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Roee  Shahar", "title": "Executive Vice President of Commercial", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 7, "overallRisk": 10, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.86, "open": 8.92, "dayLow": 8.85, "dayHigh": 9.16, "regularMarketPreviousClose": 8.86, "regularMarketOpen": 8.92, "regularMarketDayLow": 8.85, "regularMarketDayHigh": 9.16, "payoutRatio": 0.0, "beta": 2.059, "forwardPE": -3.0517242, "volume": 542652, "regularMarketVolume": 542652, "averageVolume": 1114840, "averageVolume10days": 951520, "averageDailyVolume10Day": 951520, "bid": 8.82, "ask": 8.89, "bidSize": 3, "askSize": 3, "marketCap": 770054464, "fiftyTwoWeekLow": 5.15, "fiftyTwoWeekHigh": 16.81, "priceToSalesTrailing12Months": 85.17359, "fiftyDayAverage": 8.0768, "twoHundredDayAverage": 11.447325, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 557042304, "profitMargins": 0.0, "floatShares": 69554437, "sharesOutstanding": 87011800, "sharesShort": 12481987, "sharesShortPriorMonth": 9523078, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.1436, "heldPercentInsiders": 0.16214001, "heldPercentInstitutions": 0.58124, "shortRatio": 8.07, "shortPercentOfFloat": 0.1492, "impliedSharesOutstanding": 87011800, "bookValue": 2.81, "priceToBook": 3.1494663, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -292963008, "trailingEps": -5.0, "forwardEps": -2.9, "enterpriseToRevenue": 61.613, "enterpriseToEbitda": -3.667, "52WeekChange": -0.42755497, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 8.85, "targetHighPrice": 38.0, "targetLowPrice": 20.0, "targetMeanPrice": 26.0, "targetMedianPrice": 24.0, "recommendationMean": 1.22222, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 217303008, "totalCashPerShare": 2.499, "ebitda": -151888992, "totalDebt": 4832000, "quickRatio": 4.001, "currentRatio": 4.076, "totalRevenue": 9041000, "debtToEquity": 2.667, "revenuePerShare": 0.154, "returnOnAssets": -0.49339, "returnOnEquity": -1.94629, "grossProfits": -120501000, "freeCashflow": -96318000, "operatingCashflow": -110794000, "revenueGrowth": -0.284, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -20.306059, "financialCurrency": "USD", "symbol": "IMNM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1746226714, "regularMarketTime": 1746216001, "regularMarketChangePercent": -0.11285864, "regularMarketPrice": 8.85, "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1114840, "fiftyTwoWeekLowChange": 3.7000003, "fiftyTwoWeekLowChangePercent": 0.7184467, "fiftyTwoWeekRange": "5.15 - 16.81", "fiftyTwoWeekHighChange": -7.959999, "fiftyTwoWeekHighChangePercent": -0.4735276, "fiftyTwoWeekChangePercent": -42.755497, "earningsTimestamp": 1742414700, "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747398600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -5.0, "epsForward": -2.9, "epsCurrentYear": -2.296, "priceEpsCurrentYear": -3.8545299, "fiftyDayAverageChange": 0.77320004, "fiftyDayAverageChangePercent": 0.09573098, "twoHundredDayAverageChange": -2.5973244, "twoHundredDayAverageChangePercent": -0.22689357, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-10-02", "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "exchange": "NCM", "messageBoardId": "finmb_108518404", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1601645400000, "shortName": "Immunome, Inc.", "longName": "Immunome, Inc.", "postMarketChangePercent": -0.112997, "postMarketPrice": 8.84, "postMarketChange": -0.0100002, "regularMarketChange": -0.009999275, "regularMarketDayRange": "8.85 - 9.16", "displayName": "Immunome", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]